Search results
25 cze 2019 · Recommendations for research. As part of the 2019 update, the guideline committee made 6 research recommendations on the management of pregnancy with chronic hypertension, pre-eclampsia, fetal monitoring, the use of antihypertensives in breastfeeding and advice and follow-up.
25 cze 2019 · Offer placental growth factor (PLGF)-based testing to help rule out pre-eclampsia between 20 weeks and 36 weeks and 6 days of pregnancy, if women with chronic hypertension are suspected of developing pre-eclampsia. (See the NICE diagnostics guidance on PLGF-based testing to help diagnose suspected preterm pre-eclampsia). [2019, amended 2023]
19 sie 2021 · Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.
•NICE guideline (DG23) PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor/BRAHMS PlGF plus Kryptor PE ratio).
2.0 Objective. the care and management of women with chronic hypertension, gestational hypertension, pre-eclampsia and e. 3.0 Scope . This guideline applies to all medical and midwifery staff working on the maternity unit and in community. 4.0 Main body of the document . 4.1 Link to NICE guideline NG133.
14 lis 2024 · International Academy of Perinatal Medicine (IAPM) guidelines for screening, prediction, prevention and management of pre-eclampsia to reduce maternal mortality in developing countries [2021] International Federation of Gynecology and Obstetrics
Women who develop severe pre-eclampsia and eclampsia. The guidance encompasses the principles within the NICE clinical guidance (NG133) hypertension in pregnancy: diagnosis and management, and NICE Quality Standard number 35 hypertension in pregnancy.
